Results 221 to 230 of about 49,177 (304)
Impact of prior antibiotics on infected pancreatic necrosis microbiology in ICU patients: a retrospective cohort study. [PDF]
Garret C +12 more
europepmc +1 more source
Oxidative Stress in the Tumor Immune Microenvironment: Mechanisms and Therapeutic Perspectives
Oxidative stress is involved in several key processes in cancer, including redox regulation, DNA damage, post‐translational modifications, transcriptional regulation, epigenetic modifications, metabolic reprogramming, cell death, and immune modulation. These mechanisms collectively influence tumor progression, immune evasion, and therapeutic responses,
Zhen Wang +14 more
wiley +1 more source
Huge, Infected Pancreatic Necrosis After Total Arch Replacement in a Patient With Immunoglobulin G4-Related Syndrome. [PDF]
Nakajima T +4 more
europepmc +1 more source
Historical Records of Tumours in New Zealand Marine Fishes
Tumours were first described in New Zealand marine fishes in 1982 but those early records have been difficult to access and subsequently few tumours have been collected and little has been published. This review updates records of identified tumours from teleosts in the New Zealand marine environment and may encourage more work to identify background ...
John Brian Jones
wiley +1 more source
Pathophysiology of ascites formation in cirrhosis of the liver [PDF]
Gerbes, Alexander L.
core +1 more source
This study provides reassuring evidence in favour of early skin testing in patients with SCARs, argues against the necessity of a 6‐month delay, and underscores the pivotal role of oral provocation tests in the safe reintroduction of essential therapies. ABSTRACT Background Identifying and discontinuing the offending drug(s) in severe cutaneous adverse
Zohra Chadli +8 more
wiley +1 more source
Endoscopic closure of pancreatico-colonic fistulas in a patient with persistent infected pancreatic necrosis and bacteremia. [PDF]
Baliss M, Numan L, Kiwan W.
europepmc +1 more source
ABSTRACT Pharmacologic interventions for type 1 diabetes (T1D) have advanced significantly in recent years with the advent of the first FDA approved therapy teplizumab for delaying symptomatic disease onset in 2022. Despite this progress, major hurdles remain in moving toward personalized medicine approaches for T1D.
Jasmine Pipella, Peter J. Thompson
wiley +1 more source
Changes and new entities in the 6th edition WCT of the digestive system, including structural, molecular, and diagnostic updates to standardize terminology and improve clinical relevance. Epithelial tumours are organized by site; neuroendocrine, mesenchymal and haematolymphoid tumours have dedicated chapters, with refined grading, redefined ...
Mark J Arends +48 more
wiley +1 more source
Phenol Neurolysis in Pain and Palliative Medicine
ABSTRACT Background Pain is a common symptom in palliative care and affects patients' quality of life considerably. Standard analgesics are sometimes insufficient and are associated with substantial side effects. Neurolysis, the targeted destruction of nerves using thermal or chemical agents, offers an additional option for managing localized pain in ...
Jeroen H. A. Creemers +6 more
wiley +1 more source

